Pharmaceuticals news FT.com

Eli Lilly close to buying gene-editing biotech Verve Therapeutics

Drugmaker nears $1.3bn deal in search for experimental medicines

Jun 17, 2025 - 01:45
 0
Eli Lilly close to buying gene-editing biotech Verve Therapeutics
Drugmaker nears $1.3bn deal in search for experimental medicines
Read More

Tags:

Previous Article

Parfums de niche : L'agent indépendant, maillon clé d'un marché en plein boom

Next Article

To boost Medicare Advantage profitability, Humana turns to old tactic: the annua...

Related Posts

Biotech billionaire Christian Angermayer: ‘Psychedelics can take away the fear’

Biotech billionaire Christian Angermayer: ‘Psychedelics...

May 18, 2025  0

China sees global turmoil as opportunity to be ‘business friendly’, says Novartis chief

China sees global turmoil as opportunity to be ‘busines...

May 18, 2025  0

Hims & Hers looks to offer replica obesity drugs in UK and Europe

Hims & Hers looks to offer replica obesity drugs in UK ...

Jun 3, 2025  0